Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'
| Errataetall: |
CommentOn: Eur J Heart Fail. 2021 Feb;23(2):277-285. - PMID 33070419 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:23 |
|---|---|
| Enthalten in: |
European journal of heart failure - 23(2021), 6 vom: 15. Juni, Seite 1057-1058 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Damy, Thibaud [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 10.08.2021 Date Revised 18.08.2021 published: Print-Electronic CommentOn: Eur J Heart Fail. 2021 Feb;23(2):277-285. - PMID 33070419 Citation Status MEDLINE |
|---|
| doi: |
10.1002/ejhf.2074 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM319050599 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM319050599 | ||
| 003 | DE-627 | ||
| 005 | 20231225170632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ejhf.2074 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1063.xml |
| 035 | |a (DE-627)NLM319050599 | ||
| 035 | |a (NLM)33340199 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Damy, Thibaud |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study' |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.08.2021 | ||
| 500 | |a Date Revised 18.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Eur J Heart Fail. 2021 Feb;23(2):277-285. - PMID 33070419 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Benzoxazoles |2 NLM | |
| 650 | 7 | |a Prealbumin |2 NLM | |
| 650 | 7 | |a tafamidis |2 NLM | |
| 650 | 7 | |a 8FG9H9D31J |2 NLM | |
| 700 | 1 | |a Sultan, Marla B |e verfasserin |4 aut | |
| 700 | 1 | |a Witteles, Ronald |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of heart failure |d 1999 |g 23(2021), 6 vom: 15. Juni, Seite 1057-1058 |w (DE-627)NLM106698575 |x 1879-0844 |7 nnns |
| 773 | 1 | 8 | |g volume:23 |g year:2021 |g number:6 |g day:15 |g month:06 |g pages:1057-1058 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ejhf.2074 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 23 |j 2021 |e 6 |b 15 |c 06 |h 1057-1058 | ||